Few randomized, controlled trials have investigated the efficacy of pharmacological treatment for lymphocytic colitis. Data from a new randomized, placebo-controlled trial have demonstrated the efficacy of budesonide in inducing remission of this disease; this study is an important contribution to this field.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Tysk, C., Bohr, J., Nyhlin, N., Wickbom, A. & Eriksson, S. Diagnosis and management of microscopic colitis. World J. Gastroenterol. 14, 7280–7288 (2008).
Chande, N., McDonald, J. W. & Macdonald, J. K. Interventions for treating lymphocytic colitis. Cochrane Database of Systematic Reviews Issue 2 Art. No.: CD006096. doi: 10.1002/14651858.CD006096.pub3 (2008).
Calabrese, C. et al. Mesalazine with or without cholestyramine in the treatment of microscopic colitis: randomized controlled trial. J. Gastroenterol. Hepatol. 22, 809–814 (2007).
Miehlke, S. et al. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology 136, 2092–2100 (2009).
Baert, F. et al. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 122, 20–25 (2002).
Bonderup, O. K. et al. Budesonide treatment of collagenous colitis: a randomised, double blind, placebo controlled trial with morphometric analysis. Gut 52, 248–251 (2003).
Miehlke, S. et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology 123, 978–984 (2002).
Bonderup, O. K., Hansen, J. B., Teglbjaerg, P. S., Christensen, L. A. & Fallingborg, J. F. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut 58, 68–72 (2009).
Miehlke, S. et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology 135, 1510–1516 (2008).
Hjortswang, H. et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm. Bowel Dis. doi:10.1002/ibd.20977.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Tysk, C. Remission of lymphocytic colitis with budesonide. Nat Rev Gastroenterol Hepatol 6, 506–507 (2009). https://doi.org/10.1038/nrgastro.2009.139
Issue Date:
DOI: https://doi.org/10.1038/nrgastro.2009.139
This article is cited by
-
Microscopic colitis: clinical characteristics, treatment and outcomes in an Irish population
International Journal of Colorectal Disease (2014)
